Skip to main content

#151245

Anti-Cdk2 [AN21.2]

Cat. #151245

Anti-Cdk2 [AN21.2]

Cat. #: 151245

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Cyclin-dependent kinase 2 (cdk2)

Class: Monoclonal

Application: ELISA ; WB

Reactivity: Human ; Mouse ; Xenopus laevis

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Julian Gannon

Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Cdk2 [AN21.2]
  • Alternate name: Cyclin-Dependent Kinase 2; Cell Division Protein Kinase 2; P33 Protein Kinase; CDKN2; CDC2-Related Protein Kinase; P33(CDK2)
  • Research fields: Cancer;Cell biology;Genetics
  • Clone: AN21.2
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human ; Mouse ; Xenopus laevis
  • Host: Mouse
  • Application: ELISA ; WB
  • Description: AN21.2 is useful as a general CDK antibody since it reacts with both Cdk1 and Cdk2.
  • Immunogen: Human recombinant Cdk2
  • Isotype: IgG2a
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Cyclin-dependent kinase 2 (cdk2)
  • Target background: Cdk2 is a cell cycle protein closely related to Cdk1 (Cdc2) and a useful marker of proliferation. Cdk2 binds cyclins A and E and controls progression into S-phase.

Applications

  • Application: ELISA ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Lee et al. 2012. Evid Based Complement Alternat Med. 2012:702857. PMID: 22701509.
  • Inhibition of Cell Growth and Induction of Apoptosis by Antrodia camphorata in HER-2/neu-Overexpressing Breast Cancer Cells through the Induction of ROS, Depletion of HER-2/neu, and Disruption of the PI3K/Akt Signaling Pathway.
  • Huang et al. 2008. Cell Cycle. 7(18):2846-55. PMID: 18769144.
  • ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.